Assessment of flonoltinib maleate versus ruxolitinib phosphate in intermediate- to high-risk myelofibrosis (FMF-02): study protocol for a multicenter, randomized, open-label phase IIB trial. [PDF]
Yang L +5 more
europepmc +1 more source
Clinical and hematological profile of patients with philadelphia-negative myeloproliferative neoplasms: First report from the Ecuadorian registry. [PDF]
Freire C +8 more
europepmc +1 more source
A breakthrough invasive <i>Aspergillus granulosus</i> infection following azole antifungal therapy in a patient with primary myelofibrosis: case report. [PDF]
Jaroensawang W +3 more
europepmc +1 more source
Ropeginterferon alfa-2b for prefibrotic myelofibrosis and lower-risk myelofibrosis requiring cytoreduction. [PDF]
Gill H +11 more
europepmc +1 more source
Renal Peripelvic Extramedullary Haematopoiesis in Myelofibrosis: A Rare Imaging Pitfall Assessed by Multimodality Nuclear Imaging. [PDF]
Soussi R +6 more
europepmc +1 more source
The Path Forward in MF: Small Molecules in the Limelight. [PDF]
Abruzzese E +4 more
europepmc +1 more source
Autoimmune myelofibrosis with a <i>TLR8</i> gain-of-function defect. [PDF]
Qu S +5 more
europepmc +1 more source
CD34-positive circulating cells quantification during follow-up in myeloproliferative neoplasms. [PDF]
Demoy M +14 more
europepmc +1 more source
Pernicious Anemia Resulting in Intramedullary Hemolysis, Masking Underlying Polycythemia Vera and Mild Alpha-Thalassemia-A Case Report. [PDF]
Rohner A +3 more
europepmc +1 more source
Prefibrotic myelofibrosis: recent updates in diagnosis, prognostication, and management 2026. [PDF]
Al-Zubaidi N +2 more
europepmc +1 more source

